Significant findings from the highly-anticipated EPIC-STEMI study were presented by Shamir R. Mehta, MD, MSc, FACC, during a late-breaking scientific session at the recent CRF Transcatheter Cardiovascular Therapeutics (TCT) 2022 Annual Symposium in Boston, MA.